Dr. Firuz Ibrahim Specialist Nuclear Medicine
Years of Experience : 10
Nationality : India
Languages Known : English, Malayalam, Hindi, Tamil, Urdu
Book AppointmentBiography
Dr. Firuz Ibrahim, MBBS, MD, DNB, FEBNM, is a highly accomplished specialist in the branch of nuclear medicine and holds the position of Specialist in the Department of Nuclear Medicine at Burjeel Medical City, Abu Dhabi. She has many years of experience in various nuclear medicine procedures with a special interest in nuclear oncology, radio-nuclide therapy, nuclear cardiology, neurology, and endocrine imaging interventions. Over the years of her much-awarded career, Dr. Firuz Ibrahim has successfully handled complicated and sensitive cancer cases with advanced nuclear medicine technology. She has actively participated in educating the non-nuclear medicine fraternity about the scope and prospects of Nuclear Medicine and has contributed to the efficacy of diagnosis and therapy procedures in the specialization. Other areas of her research and application include radio-nuclide therapy, dementia and Parkinson’s disease imaging, utility of FDG PET CT in pyrexia of unknown origin, PET CT in gynecological malignancies, Lymphoma and Multiple myeloma. Dr. Firuz Ibrahim received her training from a 1500-bedded high volume cancer center in South India. She also worked for another 5 years in a busy tertiary care hospital in South India, before joining Burjeel Medical City. She is a Fellow of European Board of Nuclear Medicine and has also received Master’s in Oncologic in Imaging Certificate from University of Pisa, Italy.
Awards & Achievements
- Master in Oncologic Imaging Certificate from the University of PISA, Italy Funded by European Society of Oncologic Imaging
- Certified Radiation Safety Officer (RSO) from BARC (Bhabha Atomic Research Centre, Mumbai, India)
- Arcotgajaraj Best Paper Award for an Oral Paper on Deauville Scoring of Lymphomas
- Certified ACLS (Advanced Cardiac Life Support) Provider
Research & Publications
- E-poster - Ki 67 index and standardized uptake value in 18 F FDG PET CT in lymphoma-Do they go hand in hand?
- Oral presentation - Prognostic value of interim 18 F FDG PET CT in Pediatric Hodgkin’s Lymphoma - Comparison between Deauville criteria and δ SUV max (%)
- Poster - An institutional study of pediatric and adolescent patients with differentiated thyroid carcinoma-its management and long term follows up
- Role of 18 F -FDG PET- CT and 99m Tc SESTAMIBI whole-body scintigraphy in the assessment of multiple myeloma patients-their diagnostic potential and prognostic implication
- MDP bone scan in early identification of polyarticular Aspergillosis - International journal of infectious disease
- Bronchiectasis masquerading as lung metastasis in a patient with papillary carcinoma of thyroid identified by I-131 Whole-body scintigraphy- Journal of Nuclear medicine and radiation therapy
- Lambda sign in sarcoidosis using PET/CT-Clinical case reports
- Have co-authored a chapter on the Utility of 18 F FDG PET CT in gynecological malignancies in a book awaiting publication
Education & Training
- MBBS
- MD (Nuclear Medicine)
- DNB (Nuclear Medicine)
- FEBNM (European Board of Nuclear Medicine)
- Master’s in Oncologic Imaging
Expertise
- PET CT – FDG PET CT,18 F Sodium Flouride PET CT, F18 DOPA PET CT, 18 F Choline PET CT, Gallium 68 PSMA PET CT, Gallium 68 DOTANOC PET CT and Gallium 68 Exendin PET CT.
- Gamma Camera and SPECT CT - Expertise includes all routinely done procedures including Stress Myocardial perfusion scintigraphy, Technetium MDP bone scan, Tc DTPA Renal scans, Technetium thyroid scans, lymphoscintigraphy, I-131 whole-body scintigraphy, HIDA scan, Sentinel lymphoscintigraphy, I-131 MIBG imaging and gamma probing, ROLL etc.
- Special expertise in Thyroid cancer - Radio-iodine ablation and radioiodine therapy for metastases.
- Other Therapeutic nuclear medicine procedures - Y-90 Thera sphere/Sirsphere therapy for Hepatocellular carcinoma, Rhenium 188 Lipiodol TARE for HCC, Lutetium-177 PSMA therapy for metastatic prostate cancers and Lutetium 177 DOTATATE therapy for metastatic neuroendocrine tumors and have had experience in Strontium 89 bone pain palliation therapy.
- Imaging of Dementia, Parkinson’s disease, Sarcoidosis, Charcot’s foot, infection, and pyrexia of unknown origin.
Membership
- Society of Nuclear Medicine, India
- Association of Nuclear Medicine Physicians of India
- European Society of Oncologic Imaging
- European Society of Hybrid Imaging
- European Association of Nuclear Medicine
- World Association of Radiopharmaceutical and Molecular Therapy
- Indian Medical Association
Blogs
Insights from Our Endocrinology Experts at Burjeel Hospital
Read more
Understanding Osteoporosis: Causes, Symptoms, and Prevention
Read more
Detecting Early Symptoms of Breast Cancer: A Guide for Women
Read more
